Delivery Order SPE2DB22D3004-SPE2DB24FPS27
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $5,285.68, has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,016,532 units of NARCAN 4 mg nasal spray. The contract, valued at $7,151.88, has a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 and with a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $9,519.11 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of NARCAN 4 mg nasal spray to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide NARCAN 4 mg nasal spray. The contract has a ceiling value of $8,522.14 and a performance period through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The contract has a period of performance through February 8, 2024 and a potential value of $1,079.76. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. This $1,349.70 award has a completion date of February 7, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NARCAN 4 MG NASAL SPRAY 2S. The contract has a completion date of March 4, 2024 and a potential value of $4,388.92. The contract is not set aside for any designated small business program. Amerisourcebergen Drug Corp is the prime contractor, and this delivery order was issued under an Indefinite Delivery Contract (IDC)...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,079.76 to Amerisourcebergen Drug Corp, the Corporate Office division of major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of NARCAN 4 MG nasal spray, a critical opioid overdose treatment medication, with a period of performance through February 6, 2024. This delivery order is part of a larger single-award Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NARCAN 4 MG NASAL SPRAY 2S. The contract has a potential value of $1,193.76 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order. The company also holds an indefinite delivery contract (IDC) with DLA, valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide NARCAN 4 MG NASAL SPRAY 2S. The $1,634.11 order has a completion date of February 9, 2024. This award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a range of pharmaceutical products and medical supplies to DLA Troop Support...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPS27Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NARCAN 4 MG NASAL SPRAY 2S. The contract, valued at $1,556.56, has an ultimate completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/20/24 |